Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Recurrence 1Neoplasms 1Death 1

Interventions

Cyclophosphamide 27fludarabine 19Dexamethasone 18pembrolizumab 12Rituximab 12Etoposide 11venetoclax 10pomalidomide 9Gemcitabine 9Lenalidomide 8fludarabine phosphate 7daratumumab 7Bortezomib 7glofitamab 6carfilzomib 6Vincristine 6obinutuzumab 5Temozolomide 5Prednisone 5Nivolumab 5Immunotherapy, Adoptive 5Doxorubicin 5Cytarabine 5Cisplatin 5Calcium Dobesilate 5selinexor 4cemiplimab 4Carboplatin 4Azacitidine 4zanubrutinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Quality Assurance, Health Care × 90 days × Clear all
NCT07484282 2026-04-03

Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer

National Institutes of Health Clinical Center (CC)

Withdrawn

Death, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡